ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Acting Commissioner Tells Grassley He Supports “Academic Freedom” at The Agency, but “At A Proper Time.”

December 1, 2006

Wyngaarden says NCI’s Special Authorities Are All Right With Him

May 14, 1982

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005

ASCO Growth Changes, Prepare Society for ‘90s

June 8, 1990

In Brief: Judge Declines To Block NCI Contract Award

February 24, 1995

Henderson, Weinstein, Jukes to Present AACR Award Lectures

March 6, 1987